Tag results:
lymphoid cells
Cell Therapy News
Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
[Frontiers in Immunology] The authors provide an overview of the major mechanisms used by tumor cells to evade immune defenses and they critically expose the most optimistic engineering strategies to make CAR-T cell therapy a solid option for solid tumors.
Human Immunology News
A New kCa3.1 Channel Activator SKA-346 Boosts T Cell Antitumor Response in the Immune Suppressive Microenvironment
[Biophysical Journal] The authors demonstrated that T cells exposed to high-e dose-dependently accumulated [K+]e intracellularly.
Human Immunology News
Tryptophan-Derived Microbial Metabolites Activate the Aryl Hydrocarbon Receptor in Tumor-Associated Macrophages to Suppress Anti-Tumor Immunity
[Immunity] Researchers examined the impact of aryl hydrocarbon receptor in tumor-associated macrophage function in pancreatic ductal adenocarcinoma.
Immunology of Infectious Disease News
Differential Virus-Specific IFN-Gamma Producing T Cell Responses to Marek’s Disease Virus in Chickens with B19 and B21 MHC Haplotypes
[Frontiers in Immunology] The frequencies of IFN-gamma producing pp38 and MEQ-specific T cell responses were determined in line N and line P2a chickens after infection with vaccine and/or virulent strains of Marek’s disease virus using both standard ex vivo and cultured chIFN-gamma ELISPOT assays.
Immune Regulation News
Normality Sensing Licenses Local T Cells for Innate-Like Tissue Surveillance
[Nature Immunology] Interruption of T cell antigen receptors-mediated ‘normality sensing’ had no impact on γδ T cell numbers but altered their signature phenotype, while the epidermal barrier function was compromised.
Endothelial Cell News
Apoptosis Induction in Human Lung and Colon Cancer Cells via Impeding VEGF Signaling Pathways
[Molecular Biology Reports] Researchers assessed the suppressing effect of VGB4, a vascular endothelial growth factor (VEGF) antagonist peptide with the binding ability to both VEGF receptor1 and VEGF receptor2, on VEGF-induced proliferation and migration of the human lung adenocarcinoma cell line A549 and the human colon adenocarcinoma cell line HT29.